-
2
-
-
1542329010
-
Mechanisms of pulmonary fibrosis
-
DOI 10.1146/annurev.med.55.091902.103810
-
Thannickal VJ, Toews GB, White ES, Lynch JP III and Martinez FJ: Mechanisms of pulmonary fibrosis. Annu Rev Med 55: 395-417, 2004. (Pubitemid 38316734)
-
(2004)
Annual Review of Medicine
, vol.55
, pp. 395-417
-
-
Thannickal, V.J.1
Toews, G.B.2
White, E.S.3
Lynch III, J.P.4
Martinez, F.J.5
-
4
-
-
0034011982
-
Idiopathic pulmonary fibrosis: Diagnosis and treatment. International consensus statement
-
American Thoracic Society. American Thoracic Society (ATS), and the European Respiratory Society (ERS)
-
American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med 161: 646-664, 2000.
-
(2000)
Am J Respir Crit Care Med
, vol.161
, pp. 646-664
-
-
-
5
-
-
79952717349
-
An official ATS/ERS/JRS/ALAT statement: Idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management
-
Raghu G, Collard HR, Egan JJ, et al: An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 183: 788-824, 2011.
-
(2011)
Am J Respir Crit Care Med
, vol.183
, pp. 788-824
-
-
Raghu, G.1
Collard, H.R.2
Egan, J.J.3
-
6
-
-
26844506715
-
Current and future therapeutic approaches in idiopathic pulmonary fibrosis
-
DOI 10.1183/09031936.05.00145004
-
Bouros D and Antoniou KM: Current and future therapeutic approaches in idiopathic pulmonary fibrosis. Eur Respir J 26: 693-702, 2005. (Pubitemid 41448670)
-
(2005)
European Respiratory Journal
, vol.26
, Issue.4
, pp. 693-702
-
-
Bouros, D.1
Antoniou, K.M.2
-
7
-
-
77951969449
-
Effect of oxymatrine on the replication cycle of hepatitis B virus in vitro
-
Xu WS, Zhao KK, Miao XH, et al: Effect of oxymatrine on the replication cycle of hepatitis B virus in vitro. World J Gastroenterol 16: 2028-2037, 2010.
-
(2010)
World J Gastroenterol
, vol.16
, pp. 2028-2037
-
-
Xu, W.S.1
Zhao, K.K.2
Miao, X.H.3
-
8
-
-
79951584353
-
Oxymatrine inhibits hepatitis B infection with an advantage of overcoming drug-resistance
-
Wang YP, Zhao W, Xue R, et al: Oxymatrine inhibits hepatitis B infection with an advantage of overcoming drug-resistance. Antiviral Res 89: 227-231, 2011.
-
(2011)
Antiviral Res
, vol.89
, pp. 227-231
-
-
Wang, Y.P.1
Zhao, W.2
Xue, R.3
-
9
-
-
52949129442
-
Oxymatrine attenuates intestinal ischemia/reperfusion injury in rats
-
Zhao J, Yu S, Tong L, et al: Oxymatrine attenuates intestinal ischemia/reperfusion injury in rats. Surg Today 38: 931-937, 2008.
-
(2008)
Surg Today
, vol.38
, pp. 931-937
-
-
Zhao, J.1
Yu, S.2
Tong, L.3
-
10
-
-
77949293053
-
Oxymatrine downregulates TLR4, TLR2, MyD88, and NF-kappaB and protects rat brains against focal ischemia
-
Fan H, Li L, Zhang X, et al: Oxymatrine downregulates TLR4, TLR2, MyD88, and NF-kappaB and protects rat brains against focal ischemia. Mediators Inflamm 2009: 704706, 2009.
-
(2009)
Mediators Inflamm
, vol.2009
, pp. 704706
-
-
Fan, H.1
Li, L.2
Zhang, X.3
-
11
-
-
84863775306
-
Oxymatrine ameliorates L: -arginine-induced acute pancreatitis in rats
-
Jun 2, (Epub ahead of print)
-
Zhang Z, Wang Y, Dong M, Cui J, Rong D and Dong Q: Oxymatrine ameliorates L: -arginine-induced acute pancreatitis in rats. Inflammation: Jun 2, 2011 (Epub ahead of print).
-
(2011)
Inflammation
-
-
Zhang, Z.1
Wang, Y.2
Dong, M.3
Cui, J.4
Rong, D.5
Dong, Q.6
-
12
-
-
84655176705
-
Oxymatrine diminishes the side population and inhibits the expression of beta-catenin in MCF-7 breast cancer cells
-
Zhang Y, Piao B, Hua B, et al: Oxymatrine diminishes the side population and inhibits the expression of beta-catenin in MCF-7 breast cancer cells. Med Oncol 28: (Suppl 1): S99-S107, 2010.
-
(2010)
Med Oncol
, vol.28
, Issue.SUPPL. 1
-
-
Zhang, Y.1
Piao, B.2
Hua, B.3
-
13
-
-
79959641621
-
Oxymatrine induces human pancreatic cancer PANC-1 cells apoptosis via regulating expression of Bcl-2 and IAP families, and releasing of cytochrome c
-
Ling Q, Xu X, Wei X, et al: Oxymatrine induces human pancreatic cancer PANC-1 cells apoptosis via regulating expression of Bcl-2 and IAP families, and releasing of cytochrome c. J Exp Clin Cancer Res 30: 66, 2011.
-
(2011)
J Exp Clin Cancer Res
, vol.30
, pp. 66
-
-
Ling, Q.1
Xu, X.2
Wei, X.3
-
14
-
-
79956224307
-
Oxymatrine reduces neuronal cell apoptosis by inhibiting Toll-like receptor 4/nuclear factor kappa-B-dependent inflammatory responses in traumatic rat brain injury
-
Dong XQ, Yu WH, Hu YY, Zhang ZY and Huang M: Oxymatrine reduces neuronal cell apoptosis by inhibiting Toll-like receptor 4/nuclear factor kappa-B-dependent inflammatory responses in traumatic rat brain injury. Inflamm Res 60: 533-539, 2011.
-
(2011)
Inflamm Res
, vol.60
, pp. 533-539
-
-
Dong, X.Q.1
Yu, W.H.2
Hu, Y.Y.3
Zhang, Z.Y.4
Huang, M.5
-
15
-
-
44849092456
-
Effect of Oxymatrine on the TGFbeta-Smad signaling pathway in rats with CCl4-induced hepatic fibrosis
-
Wu XL, Zeng WZ, Jiang MD, Qin JP and Xu H: Effect of Oxymatrine on the TGFbeta-Smad signaling pathway in rats with CCl4-induced hepatic fibrosis. World J Gastroenterol 14: 2100-2105, 2008.
-
(2008)
World J Gastroenterol
, vol.14
, pp. 2100-2105
-
-
Wu, X.L.1
Zeng, W.Z.2
Jiang, M.D.3
Qin, J.P.4
Xu, H.5
-
16
-
-
79955645935
-
The neuroprotection of oxymatrine in cerebral ischemia/reperfusion is related to nuclear factor erythroid 2-related factor 2 (nrf2)-mediated antioxidant response: Role of nrf2 and hemeoxygenase-1 expression
-
Li M, Zhang X, Cui L, et al: The neuroprotection of oxymatrine in cerebral ischemia/reperfusion is related to nuclear factor erythroid 2-related factor 2 (nrf2)-mediated antioxidant response: role of nrf2 and hemeoxygenase-1 expression. Biol Pharm Bull 34: 595-601, 2011.
-
(2011)
Biol Pharm Bull
, vol.34
, pp. 595-601
-
-
Li, M.1
Zhang, X.2
Cui, L.3
-
17
-
-
78649637007
-
Antiarrhythmic effects and ionic mechanisms of oxymatrine from Sophora flavescens
-
Cao YG, Jing S, Li L, et al: Antiarrhythmic effects and ionic mechanisms of oxymatrine from Sophora flavescens. Phytother Res 24: 1844-1849, 2010.
-
(2010)
Phytother Res
, vol.24
, pp. 1844-1849
-
-
Cao, Y.G.1
Jing, S.2
Li, L.3
-
18
-
-
49749085492
-
Attenuation of bleomycin-induced lung fibrosis by oxymatrine is associated with regulation of fibroblast proliferation and collagen production in primary culture
-
Chen X, Sun R, Hu J, et al: Attenuation of bleomycin-induced lung fibrosis by oxymatrine is associated with regulation of fibroblast proliferation and collagen production in primary culture. Basic Clin Pharmacol Toxicol 103: 278-286, 2008.
-
(2008)
Basic Clin Pharmacol Toxicol
, vol.103
, pp. 278-286
-
-
Chen, X.1
Sun, R.2
Hu, J.3
-
19
-
-
33846850150
-
Nitric oxide in the pathogenesis of diffuse pulmonary fibrosis
-
Hsu YC, Wang LF and Chien YW: Nitric oxide in the pathogenesis of diffuse pulmonary fibrosis. Free Radic Biol Med 42: 599-607, 2007.
-
(2007)
Free Radic Biol Med
, vol.42
, pp. 599-607
-
-
Hsu, Y.C.1
Wang, L.F.2
Chien, Y.W.3
-
20
-
-
2342482002
-
Nitric oxide in health and disease of the respiratory system
-
DOI 10.1152/physrev.00034.2003
-
Ricciardolo FL, Sterk PJ, Gaston B and Folkerts G: Nitric oxide in health and disease of the respiratory system. Physiol Rev 84: 731-765, 2004. (Pubitemid 38823765)
-
(2004)
Physiological Reviews
, vol.84
, Issue.3
, pp. 731-765
-
-
Ricciardolo, F.L.M.1
Sterk, P.J.2
Gaston, B.3
Folkerts, G.4
-
21
-
-
0028026868
-
Nitric oxide synthase: Aspects concerning structure and catalysis
-
Marletta MA: Nitric oxide synthase: aspects concerning structure and catalysis. Cell 78: 927-930, 1994.
-
(1994)
Cell
, vol.78
, pp. 927-930
-
-
Marletta, M.A.1
-
22
-
-
0030915094
-
Increased production of the potent oxidant peroxynitrite in the lungs of patients with idiopathic pulmonary fibrosis
-
Saleh D, Barnes PJ and Giaid A: Increased production of the potent oxidant peroxynitrite in the lungs of patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 155: 1763-1769, 1997. (Pubitemid 27216690)
-
(1997)
American Journal of Respiratory and Critical Care Medicine
, vol.155
, Issue.5
, pp. 1763-1769
-
-
Saleh, D.1
Barnes, P.J.2
Giaid, A.3
-
23
-
-
0032948112
-
Inhibition of nitric oxide synthase as a potential therapeutic target
-
DOI 10.1146/annurev.pharmtox.39.1.191
-
Hobbs AJ, Higgs A and Moncada S: Inhibition of nitric oxide synthase as a potential therapeutic target. Annu Rev Pharmacol Toxicol 39: 191-220, 1999. (Pubitemid 29222557)
-
(1999)
Annual Review of Pharmacology and Toxicology
, vol.39
, pp. 191-220
-
-
Hobbs, A.J.1
Higgs, A.2
Moncada, S.3
-
24
-
-
0033839060
-
Suppression of bleomycin-induced nitric oxide production in mice by taurine and niacin
-
DOI 10.1006/niox.2000.0297
-
Gurujeyalakshmi G, Wang Y and Giri SN: Suppression of bleomycin-induced nitric oxide production in mice by taurine and niacin. Nitric Oxide 4: 399-411, 2000. (Pubitemid 30665222)
-
(2000)
Nitric Oxide - Biology and Chemistry
, vol.4
, Issue.4
, pp. 399-411
-
-
Gurujeyalakshmi, G.1
Wang, Y.2
Giri, S.N.3
-
25
-
-
0034960535
-
3 mRNA transcripts in normal and fibrotic human lung
-
DOI 10.1136/thorax.56.7.549
-
Coker RK, Laurent GJ, Jeffery PK, du Bois RM, Black CM and McAnulty RJ: Localisation of transforming growth factor beta1 and beta3 mRNA transcripts in normal and fibrotic human lung. Thorax 56: 549-556, 2001. (Pubitemid 32588534)
-
(2001)
Thorax
, vol.56
, Issue.7
, pp. 549-556
-
-
Coker, R.K.1
Laurent, G.J.2
Jeffery, P.K.3
Du, B.R.M.4
Black, C.M.5
McAnulty, R.J.6
-
26
-
-
0025984699
-
The role of TGF-beta in pulmonary fibrosis
-
Khalil N and Greenberg AH: The role of TGF-beta in pulmonary fibrosis. Ciba Found Symp 157: 194-211, 1991.
-
(1991)
Ciba Found Symp
, vol.157
, pp. 194-211
-
-
Khalil, N.1
Greenberg, A.H.2
-
28
-
-
0035710746
-
-DeltaDeltaCT method
-
DOI 10.1006/meth.2001.1262
-
Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25: 402-408, 2001. (Pubitemid 34164012)
-
(2001)
Methods
, vol.25
, Issue.4
, pp. 402-408
-
-
Livak, K.J.1
Schmittgen, T.D.2
-
29
-
-
34248577489
-
Effects of curcumin in treatment of experimental pulmonary fibrosis: A comparison with hydrocortisone
-
DOI 10.1016/j.jep.2007.03.011, PII S0378874107001341
-
Xu M, Deng B, Chow YL, Zhao ZZ and Hu B: Effects of curcumin in treatment of experimental pulmonary fibrosis: a comparison with hydrocortisone. J Ethnopharmacol 112: 292-299, 2007. (Pubitemid 46756074)
-
(2007)
Journal of Ethnopharmacology
, vol.112
, Issue.2
, pp. 292-299
-
-
Xu, M.1
Deng, B.2
Chow, Y.-l.3
Zhao, Z.-z.4
Hu, B.5
-
30
-
-
0026734789
-
Bleomycin stimulation of cytokine secretion by the human alveolar macrophage
-
Scheule RK, Perkins RC, Hamilton R and Holian A: Bleomycin stimulation of cytokine secretion by the human alveolar macrophage. Am J Physiol 262: L386-L391, 1992.
-
(1992)
Am J Physiol
, vol.262
-
-
Scheule, R.K.1
Perkins, R.C.2
Hamilton, R.3
Holian, A.4
-
31
-
-
0026059699
-
Mechanisms of bleomycin-induced lung damage
-
Hay J, Shahzeidi S and Laurent G: Mechanisms of bleomycin-induced lung damage. Arch Toxicol 65: 81-94, 1991.
-
(1991)
Arch Toxicol
, vol.65
, pp. 81-94
-
-
Hay, J.1
Shahzeidi, S.2
Laurent, G.3
-
32
-
-
39149103740
-
The bleomycin animal model: A useful tool to investigate treatment options for idiopathic pulmonary fibrosis?
-
DOI 10.1016/j.biocel.2007.08.011, PII S1357272507002877
-
Moeller A, Ask K, Warburton D, Gauldie J and Kolb M: The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis? Int J Biochem Cell Biol 40: 362-382, 2008. (Pubitemid 351249887)
-
(2008)
International Journal of Biochemistry and Cell Biology
, vol.40
, Issue.3
, pp. 362-382
-
-
Moeller, A.1
Ask, K.2
Warburton, D.3
Gauldie, J.4
Kolb, M.5
-
33
-
-
80051718091
-
Modeling pulmonary fibrosis with bleomycin
-
Mouratis MA and Aidinis V: Modeling pulmonary fibrosis with bleomycin. Curr Opin Pulm Med 17: 355-361, 2011.
-
(2011)
Curr Opin Pulm Med
, vol.17
, pp. 355-361
-
-
Mouratis, M.A.1
Aidinis, V.2
-
34
-
-
68049129556
-
Oxidative stress in the pathogenesis of diffuse lung diseases: A review
-
Bargagli E, Olivieri C, Bennett D, Prasse A, Muller-Quernheim J and Rottoli P: Oxidative stress in the pathogenesis of diffuse lung diseases: a review. Respir Med 103: 1245-1256, 2009.
-
(2009)
Respir Med
, vol.103
, pp. 1245-1256
-
-
Bargagli, E.1
Olivieri, C.2
Bennett, D.3
Prasse, A.4
Muller-Quernheim, J.5
Rottoli, P.6
-
35
-
-
23644461803
-
Oxidative stress in pulmonary fibrosis: A possible role for redox modulatory therapy
-
DOI 10.1164/rccm.200501-017PP
-
Kinnula VL, Fattman CL, Tan RJ and Oury TD: Oxidative stress in pulmonary fibrosis: a possible role for redox modulatory therapy. Am J Respir Crit Care Med 172: 417-422, 2005. (Pubitemid 41117386)
-
(2005)
American Journal of Respiratory and Critical Care Medicine
, vol.172
, Issue.4
, pp. 417-422
-
-
Kinnula, V.L.1
Fattman, C.L.2
Tan, R.J.3
Oury, T.D.4
-
36
-
-
33644634884
-
Effects of oxymatrine on proliferation and apoptosis in human hepatoma cells
-
Song G, Luo Q, Qin J, Wang L, Shi Y and Sun C: Effects of oxymatrine on proliferation and apoptosis in human hepatoma cells. Colloids Surf B Biointerfaces 48: 1-5, 2006.
-
(2006)
Colloids Surf B Biointerfaces
, vol.48
, pp. 1-5
-
-
Song, G.1
Luo, Q.2
Qin, J.3
Wang, L.4
Shi, Y.5
Sun, C.6
-
37
-
-
0036318611
-
P-selectin upregulation in bleomycin induced lung injury in rats: Effect of N-acetyl-L-cysteine
-
DOI 10.1136/thorax.57.7.629
-
Serrano-Mollar A, Closa D, Cortijo J, et al: P-selectin upregulation in bleomycin induced lung injury in rats: effect of N-acetyl-L-cysteine. Thorax 57: 629-634, 2002. (Pubitemid 34761767)
-
(2002)
Thorax
, vol.57
, Issue.7
, pp. 629-634
-
-
Serrano-Mollar, A.1
Closa, D.2
Cortijo, J.3
Morcillo, E.J.4
Prats, N.5
Gironella, M.6
Panes, J.7
Rosello-Catafau, J.8
Bulbena, O.9
-
38
-
-
62949146206
-
Cytokine gene polymorphisms and BALF cytokine levels in interstitial lung diseases
-
Vasakova M, Sterclova M, Kolesar L, et al: Cytokine gene polymorphisms and BALF cytokine levels in interstitial lung diseases. Respir Med 103: 773-779, 2009.
-
(2009)
Respir Med
, vol.103
, pp. 773-779
-
-
Vasakova, M.1
Sterclova, M.2
Kolesar, L.3
-
39
-
-
79953011499
-
GW0742, a high affinity PPAR-beta/delta agonist reduces lung inflammation induced by bleomycin instillation in mice
-
Galuppo M, Di Paola R, Mazzon E, et al: GW0742, a high affinity PPAR-beta/delta agonist reduces lung inflammation induced by bleomycin instillation in mice. Int J Immunopathol Pharmacol 23: 1033-1046, 2010.
-
(2010)
Int J Immunopathol Pharmacol
, vol.23
, pp. 1033-1046
-
-
Galuppo, M.1
Di Paola, R.2
Mazzon, E.3
-
40
-
-
79953733330
-
Adrenomedullin in inflammatory process associated with experimental pulmonary fibrosis
-
Di Paola R, Talero E, Galuppo M, et al: Adrenomedullin in inflammatory process associated with experimental pulmonary fibrosis. Respir Res 12: 41, 2011.
-
(2011)
Respir Res
, vol.12
, pp. 41
-
-
Di Paola, R.1
Talero, E.2
Galuppo, M.3
-
41
-
-
79959378797
-
MEK inhibition suppresses the development of lung fibrosis in the bleomycin model
-
Galuppo M, Esposito E, Mazzon E, et al: MEK inhibition suppresses the development of lung fibrosis in the bleomycin model. Naunyn Schmiedebergs Arch Pharmacol 384: 21-37, 2011.
-
(2011)
Naunyn Schmiedebergs Arch Pharmacol
, vol.384
, pp. 21-37
-
-
Galuppo, M.1
Esposito, E.2
Mazzon, E.3
-
42
-
-
0036142953
-
Inducible nitric oxide synthase, but not xanthine oxidase, is highly expressed in interstitial pneumonias and granulomatous diseases of human lung
-
DOI 10.1309/W7T9-HW9V-V94B-R9KM
-
Lakari E, Soini Y, Saily M, Koistinen P, Paakko P and Kinnula VL: Inducible nitric oxide synthase, but not xanthine oxidase, is highly expressed in interstitial pneumonias and granulomatous diseases of human lung. Am J Clin Pathol 117: 132-142, 2002. (Pubitemid 34052483)
-
(2002)
American Journal of Clinical Pathology
, vol.117
, Issue.1
, pp. 132-142
-
-
Lakari, E.1
Soini, Y.2
Saily, M.3
Koistinen, P.4
Paakko, P.5
Kinnula, V.L.6
-
43
-
-
1242306647
-
The Role of Transforming Growth Factor beta in Lung Development and Disease
-
DOI 10.1378/chest.125.2.754
-
Bartram U and Speer CP: The role of transforming growth factor beta in lung development and disease. Chest 125: 754-765, 2004. (Pubitemid 38223659)
-
(2004)
Chest
, vol.125
, Issue.2
, pp. 754-765
-
-
Bartram, U.1
Speer, C.P.2
-
44
-
-
0027425864
-
Effect of antibody to transforming growth factor beta on bleomycin induced accumulation of lung collagen in mice
-
Giri SN, Hyde DM and Hollinger MA: Effect of antibody to transforming growth factor beta on bleomycin induced accumulation of lung collagen in mice. Thorax 48: 959-966, 1993. (Pubitemid 23319618)
-
(1993)
Thorax
, vol.48
, Issue.10
, pp. 959-966
-
-
Giri, S.N.1
Hyde, D.M.2
Hollinger, M.A.3
-
45
-
-
0030709198
-
Antifibrotic effect of decorin in a bleomycin hamster model of lung fibrosis
-
DOI 10.1016/S0006-2952(97)00343-2, PII S0006295297003432
-
Giri SN, Hyde DM, Braun RK, Gaarde W, Harper JR and Pierschbacher MD: Antifibrotic effect of decorin in a bleomycin hamster model of lung fibrosis. Biochem Pharmacol 54: 1205-1216, 1997. (Pubitemid 27497247)
-
(1997)
Biochemical Pharmacology
, vol.54
, Issue.11
, pp. 1205-1216
-
-
Giri, S.N.1
Hyde, D.M.2
Braun, R.K.3
Gaarde, W.4
Harper, J.R.5
Pierschbacher, M.D.6
-
46
-
-
0035083956
-
Transient transgene expression of decorin in the lung reduces the fibrotic response to bleomycin
-
Kolb M, Margetts PJ, Galt T, et al: Transient transgene expression of decorin in the lung reduces the fibrotic response to bleomycin. Am J Respir Crit Care Med 163: 770-777, 2001. (Pubitemid 32230842)
-
(2001)
American Journal of Respiratory and Critical Care Medicine
, vol.163
, Issue.3 I
, pp. 770-777
-
-
Kolb, M.1
Margetts, P.J.2
Galt, T.3
Sime, P.J.4
Xing, Z.5
Schmidt, M.6
Gauldie, J.7
-
47
-
-
79251639838
-
Therapeutic effect of a peptide inhibitor of TGF-beta on pulmonary fibrosis
-
Arribillaga L, Dotor J, Basagoiti M, et al: Therapeutic effect of a peptide inhibitor of TGF-beta on pulmonary fibrosis. Cytokine 53: 327-333, 2011.
-
(2011)
Cytokine
, vol.53
, pp. 327-333
-
-
Arribillaga, L.1
Dotor, J.2
Basagoiti, M.3
-
48
-
-
0036086293
-
Smad3 deficiency attenuates bleomycin-induced pulmonary fibrosis in mice
-
Zhao J, Shi W, Wang YL, et al: Smad3 deficiency attenuates bleomycin-induced pulmonary fibrosis in mice. Am J Physiol Lung Cell Mol Physiol 282: L585-L593, 2002. (Pubitemid 34654664)
-
(2002)
American Journal of Physiology - Lung Cellular and Molecular Physiology
, vol.282
, Issue.3
-
-
Zhao, J.1
Shi, W.2
Wang, Y.-L.3
Chen, H.4
Bringas Jr., P.5
Datto, M.B.6
Frederick, J.P.7
Wang, X.-F.8
Warburton, D.9
-
49
-
-
58149459331
-
VEGFR-2 antagonist SU5416 attenuates bleomycin-induced pulmonary fibrosis in mice
-
Ou XM, Li WC, Liu DS, et al: VEGFR-2 antagonist SU5416 attenuates bleomycin-induced pulmonary fibrosis in mice. Int Immunopharmacol 9: 70-79, 2009.
-
(2009)
Int Immunopharmacol
, vol.9
, pp. 70-79
-
-
Ou, X.M.1
Li, W.C.2
Liu, D.S.3
-
50
-
-
70249113403
-
Blockade of advanced glycation end product formation attenuates bleomycin-induced pulmonary fibrosis in rats
-
Chen L, Wang T, Wang X, et al: Blockade of advanced glycation end product formation attenuates bleomycin-induced pulmonary fibrosis in rats. Respir Res 10: 55, 2009.
-
(2009)
Respir Res
, vol.10
, pp. 55
-
-
Chen, L.1
Wang, T.2
Wang, X.3
-
51
-
-
73449146238
-
Neferine, a bisbenzylisoquinline alkaloid attenuates bleomycin-induced pulmonary fibrosis
-
Zhao L, Wang X, Chang Q, et al: Neferine, a bisbenzylisoquinline alkaloid attenuates bleomycin-induced pulmonary fibrosis. Eur J Pharmacol 627: 304-312, 2010.
-
(2010)
Eur J Pharmacol
, vol.627
, pp. 304-312
-
-
Zhao, L.1
Wang, X.2
Chang, Q.3
-
52
-
-
79958116138
-
Antifibrosis effects of total glucosides of Danggui-Buxue-Tang in a rat model of bleomycin-induced pulmonary fibrosis
-
Gao J, Huang Y, Li P, et al: Antifibrosis effects of total glucosides of Danggui-Buxue-Tang in a rat model of bleomycin-induced pulmonary fibrosis. J Ethnopharmacol 136: 21-26, 2011.
-
(2011)
J Ethnopharmacol
, vol.136
, pp. 21-26
-
-
Gao, J.1
Huang, Y.2
Li, P.3
|